儿科关键性喘中的静脉支气管扩展剂:系统性审查和网络元分析
Samer Abu-Sultaneh1, Andrew G Miller2,3,4, Sangita Basnet5
1Division of Pediatric Critical Care Medicine, Department of Pediatrics, Indiana University School of Medicine and Riley Hospital for Children at Indiana University Health, Indianapolis, Indiana, USA.
Pediatric pulmonology
|July 10, 2025
概括
静脉注射硫酸 (MgSO4) 是对儿科重症喘最有前途的第一个辅助支气管扩展剂,可减少住院时间和PICU入院. 需要进一步的试验来确认其常规使用.
科学领域:
- 儿科重症监护医学 儿科重症监护医学
- 药理学 药理学是指药理学的学科.
- 呼吸系统医学 呼吸系统医学
背景情况:
- 儿科关键性喘是PICU入院的常见原因.
- 当初始治疗失败时,使用辅助静脉注射 (IV) 支气管扩展剂.
- 目前的指南缺乏对IV支气管扩展剂有效性的排名.
研究的目的:
- 为了比较不同IV支气管扩展剂在儿科关键性喘中的有效性.
- 根据以患者为中心的结果对IV支气管扩展剂进行排名.
- 为了确定最佳的第一线IV支气管扩展剂.
主要方法:
- 来自MEDLINE,Embase和CINAHL的随机对照试验的系统审查.
- 贝叶斯网络的元分析比较了IV硫酸,IV甲基丁和IVSABA.
- 结果包括住院时间,PICU入院,PICU住院时间和输管率.
主要成果:
- 输液硫酸 (MgSO4) 在医院LOS,PICU入院和PICU LOS中显示出最大的减少.
- IV MgSO4在医院LOS,PICU入院和PICU LOS (SUCRA>0.88) 中排名第一.
- 在敏感性分析中,IV MgSO4显示了最低的输管率 (SUCRA 0.921).
结论:
- IV MgSO4是最有前途的第一个辅助IV支气管扩展剂,用于儿科关键性喘.
- IV MgSO4表现出优异的结果和有利的安全性.
- 需要进一步进行高质量的试验,以确定IV MgSO4作为常规的一线药物.
关键词:
氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基氨基支气管扩展剂 支气管扩展剂孩子们的孩子们的孩子们的孩子们关键性喘 严重的喘硫酸硫酸是一种硫酸.甲基克桑提因 (Methylxanthines) 是一种含有甲基的物质.网络元分析 网络元分析盐胺醇的使用方法状态 喘病患者丁氨酸 (terbutaline) 是一种有毒的药物.更多相关视频
相关概念视频
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:26COPD: Management Using Bronchodilators and Corticosteroids
322
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
322
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
394
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
394
01:23Inhaled Medications
398
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
398
01:17Drugs Used in Lower Respiratory Disorders: Overview
610
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
610
01:30Asthma-IV: Nursing Management
3.3K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.3K